FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pharmacology and cell technologies. Medication, possessing regenerative activity, represents granulocytic colony-stimulating factor, immobilised on water-soluble polymers with molecular weight 400-4000 Da. Granulocytic colony-stimulating factor is immobilised on water-soluble polymers by means of ionising radiation - flow of accelerated electrons with energy 2.5 MeV, absorbed dose from 2 to 10 kGy and rate of dose gain 1.65 kGy/hour.
EFFECT: medication by claimed invention does not have immunogenicity, is highly efficient both in parenteral and peroral introduction.
10 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
METHOD FOR CORRECTION OF REMOTE CONSEQUENCES OF SPERMATOGENESIS CAUSED BY CYTOSTATIC EXPOSURE | 2013 |
|
RU2535002C2 |
AGENT FOR INCREASING RESERVED STEM CELL NUMBER IN ORGANISM | 2009 |
|
RU2405822C1 |
AGENT FOR BODY GROWTH STIMULATION | 2011 |
|
RU2452509C1 |
MEANS FOR CORRECTION OF OVARY DAMAGE CAUSED BY CYTOSTATIC EFFECT | 2021 |
|
RU2785397C1 |
HAEMOSTIMULATING MEDICATION | 2010 |
|
RU2437675C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
Authors
Dates
2010-12-20—Published
2009-03-05—Filed